To determine if the reduction in promoter B transcript levels is a characteristic of osteosarcoma tumor tissue, we measured WNT5A promoter A and B transcript levels in osteosarcoma tissue from three individual patients. This evidence concerns the gene WNT5A and osteosarcoma.